Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (25,652)

Search Parameters:
Keywords = by heart

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
25 pages, 1690 KiB  
Review
Practical Considerations in the Management of Frail Older People with Diabetes
by Dima Abdelhafiz and Ahmed Abdelhafiz
Diseases 2025, 13(8), 249; https://doi.org/10.3390/diseases13080249 (registering DOI) - 6 Aug 2025
Abstract
With increasing life expectancy, the number of older people living with comorbid diabetes and frailty is increasing. The development of frailty accelerates diabetes-related adverse outcomes. Frailty is a multidimensional syndrome with physical, mental and social aspects which is associated with increased risk of [...] Read more.
With increasing life expectancy, the number of older people living with comorbid diabetes and frailty is increasing. The development of frailty accelerates diabetes-related adverse outcomes. Frailty is a multidimensional syndrome with physical, mental and social aspects which is associated with increased risk of hypoglycaemia, dementia and hospitalisation. Therefore, regular screening for all aspects of frailty should be an integrated part of the care plans of older people with diabetes. In addition, every effort should be made for prevention, which includes adequate nutrition combined with regular resistance exercise training. In already frail older people with diabetes, metabolic targets should be relaxed and hypoglycaemic agents should be of low hypoglycaemic risk potential. Furthermore, the metabolic phenotype of frailty should be considered when choosing hypoglycaemic agents and determining targets. With increasing severity of frailty, proactive chronological plans of de-escalation, palliation and end-of-life care should be considered. These plans should be undertaken in a shared decision-making manner which involves patients and their families. This ensures that patients’ views, wishes and preferences are in the heart of these plans. Full article
Show Figures

Figure 1

13 pages, 1424 KiB  
Article
Comparison of Artificial Intelligence–Derived Heart Age with Chronological Age Using Normal Sinus Electrocardiograms in Patients with No Evidence of Cardiac Disease
by Myoung Jung Kim, Sung-Hee Song, Young Jun Park, Young-Hyun Lee, Jongwoo Kim, JaeHu Jeon, KyungChang Woo, Juwon Kim, Ju Youn Kim, Seung-Jung Park, Young Keun On and Kyoung-Min Park
J. Clin. Med. 2025, 14(15), 5548; https://doi.org/10.3390/jcm14155548 (registering DOI) - 6 Aug 2025
Abstract
Background/Objectives: Chronological age (CA) is commonly used in clinical decision-making, yet it may not accurately reflect biological aging. Recent advances in artificial intelligence (AI) allow estimation of electrocardiogram (ECG)-derived heart age, which may serve as a non-invasive biomarker for physiological aging. This [...] Read more.
Background/Objectives: Chronological age (CA) is commonly used in clinical decision-making, yet it may not accurately reflect biological aging. Recent advances in artificial intelligence (AI) allow estimation of electrocardiogram (ECG)-derived heart age, which may serve as a non-invasive biomarker for physiological aging. This study aimed to develop and validate a deep learning model to predict ECG-heart age in individuals with no structural heart disease. Methods: We trained a convolutional neural network (DenseNet-121) using 12-lead ECGs from 292,484 individuals (mean age: 51.4 ± 13.8 years; 42.3% male) without significant cardiac disease. Exclusion criteria included missing age data, age <18 or >90 years, and structural abnormalities. CA was used as the target variable. Model performance was evaluated using the coefficient of determination (R2), Pearson correlation coefficient (PCC), mean absolute error (MAE), and root mean square error (RMSE). External validation was conducted using 1191 independent ECGs. Results: The model demonstrated strong predictive performance (R2 = 0.783, PCC = 0.885, MAE = 5.023 years, RMSE = 6.389 years). ECG-heart age tended to be overestimated in younger adults (≤30 years) and underestimated in older adults (≥70 years). External validation showed consistent performance (R2 = 0.703, PCC = 0.846, MAE = 5.582 years, RMSE = 7.316 years). Conclusions: The proposed AI-based model accurately estimates ECG-heart age in individuals with structurally normal hearts. ECG-derived heart age may serve as a reliable biomarker of biological aging and support future risk stratification strategies. Full article
(This article belongs to the Section Cardiology)
Show Figures

Figure 1

18 pages, 7706 KiB  
Review
The Role of Imaging in Ventricular Tachycardia Ablation
by Pasquale Notarstefano, Michele Ciabatti, Carmine Marallo, Mirco Lazzeri, Aureliano Fraticelli, Valentina Tavanti, Giulio Zucchelli, Angelica La Camera and Leonardo Bolognese
Diagnostics 2025, 15(15), 1973; https://doi.org/10.3390/diagnostics15151973 (registering DOI) - 6 Aug 2025
Abstract
Ventricular tachycardia (VT) remains a major cause of morbidity and mortality in patients with structural heart disease. While catheter ablation has become a cornerstone in VT management, recurrence rates remain substantial due to limitations in electroanatomic mapping (EAM), particularly in cases of deep [...] Read more.
Ventricular tachycardia (VT) remains a major cause of morbidity and mortality in patients with structural heart disease. While catheter ablation has become a cornerstone in VT management, recurrence rates remain substantial due to limitations in electroanatomic mapping (EAM), particularly in cases of deep or heterogeneous arrhythmogenic substrates. Cardiac imaging, especially when multimodal and integrated with mapping systems, has emerged as a critical adjunct to enhance procedural efficacy, safety, and individualized strategy. This comprehensive review explores the evolving role of various imaging modalities, including echocardiography, cardiac magnetic resonance (CMR), computed tomography (CT), positron emission tomography (PET), and intracardiac echocardiography (ICE), in the preprocedural and intraprocedural phases of VT ablation. We highlight their respective strengths in substrate identification, anatomical delineation, and real-time guidance. While limitations persist, including costs, availability, artifacts in device carriers, and lack of standardization, future advances are likely to redefine procedural workflows. Full article
(This article belongs to the Special Issue Advances in Diagnosis and Treatment of Cardiac Arrhythmias 2025)
Show Figures

Figure 1

18 pages, 551 KiB  
Article
Mortality During In-Hospital Stay and the First 24 h After Decompressive Craniectomy in Severe Traumatic Brain Injury: A Multi-Center, Retrospective Propensity Score-Matched Study
by Thomas Kapapa, Martin Petkov, Andrej Pala, Dieter Woischneck, Franziska Schiller, Stefanie Jesuthasan, Frederike Schiller, Hendrik Bracht, Benjamin Mayer and Marcel Oehmichen
J. Clin. Med. 2025, 14(15), 5540; https://doi.org/10.3390/jcm14155540 (registering DOI) - 6 Aug 2025
Abstract
Objectives: Early death after trauma has been described several times. Little is known about it after traumatic brain injury (TBI) and decompressive craniectomy (DC). The aim of this study was to characterize patients who die after a TBI and DC during their [...] Read more.
Objectives: Early death after trauma has been described several times. Little is known about it after traumatic brain injury (TBI) and decompressive craniectomy (DC). The aim of this study was to characterize patients who die after a TBI and DC during their in-hospital stay. Methods: In a subgroup analysis of a retrospective, multicenter, and observational study, non-survivors from in-hospital stays treated for severe TBI and DC were included. Propensity score matching (PSM) was used. Results: A total of 223 patients with severe TBI were treated with DC, and there were 65 (29.1%) patients who did not survive. Of these, 22 (33.8%) died within the first 24 h. Non-survivors were older (p = 0.010), and pupillomotor dysfunction and a higher heart rate on admission were more common (p < 0.001). PSM patients for overall survival (41, 18.4%) differed in mean heart rate from the deceased (p = 0.030). In a multivariate model, age (OR: 1.045, p = 0.013, CI95%: 1.010 to 1.082), Quick value (OR: 0.965, p = 0.049, CI95%: 0.931 to 1.000), and heart rate (OR: 1.099, p = 0.030, CI95%: 1.009 to 1.197) were confirmed as predictive factors. Conclusions: Even after DC, known factors, such as chronological age and comorbidities, have a significant influence on mortality. The value of DC in an aging society for a particular severity of TBI should be further assessed on the basis of prospective studies. Full article
Show Figures

Figure 1

13 pages, 1183 KiB  
Article
Head-to-Head Comparison of Meril Myval Series Balloon-Expandable and Abbott Portico Series Self-Expanding Transcatheter Aortic Valves—A Single-Center Experience
by Matjaž Bunc, Gregor Verček, Luka Vitez, Primož Holc, Klemen Steblovnik and Miha Šušteršič
Medicina 2025, 61(8), 1419; https://doi.org/10.3390/medicina61081419 - 6 Aug 2025
Abstract
Background and Objectives: Transcatheter heart valve (THV) selection is challenging as self-expanding valves (SEVs) are associated with lower post-procedural mean aortic gradients, while balloon-expandable valves (BEVs) have lower rates of paravalvular leak (PVL) and permanent pacemaker implantation (PPI). We aimed to compare [...] Read more.
Background and Objectives: Transcatheter heart valve (THV) selection is challenging as self-expanding valves (SEVs) are associated with lower post-procedural mean aortic gradients, while balloon-expandable valves (BEVs) have lower rates of paravalvular leak (PVL) and permanent pacemaker implantation (PPI). We aimed to compare the 30-day and 1-year outcomes following Myval BEV (Meril Life Sciences, Vapi, Gujarat, India) and intra-annular Portico SEV (Abbott, St. Paul, MN, USA) implantation. Materials and Methods: We retrospectively analyzed the data from the all-comer TAVI registry of the University Medical Centre Ljubljana, Slovenia, from October 2017 to August 2023. Safety and efficacy outcomes following Myval BEV and Portico SEV implantation were compared overall and after propensity score matching. Results: Of the total 1152 THVs implanted, 97 patients (8%) received a Myval BEV and 47 (4%) a Portico SEV. After propensity score matching, there were no significant differences between the two patient cohorts regarding 30-day (Myval 0.0% vs. Portico 2.9%, p = 1.000) and 1-year mortality (Myval 0.0% vs. Portico 5.9%, p = 0.492). Likewise, the rates of new PPI, device failure (mean aortic gradient and more than mild PVL), and periprocedural in-hospital complications were comparable between the two groups. Conclusions: In this retrospective analysis of two intra-annular THVs, the Myval BEV was associated with comparable short- and mid-term outcomes as the Portico SEV. Full article
(This article belongs to the Section Cardiology)
Show Figures

Figure 1

10 pages, 223 KiB  
Article
Lipoprotein(a) Levels in Heart Failure with Reduced and Preserved Ejection Fraction: A Retrospective Analysis
by Alaukika Agarwal, Rubab Sohail and Supreeti Behuria
Hearts 2025, 6(3), 20; https://doi.org/10.3390/hearts6030020 - 6 Aug 2025
Abstract
Background/Objectives: While elevated Lp(a) levels are associated with incident heart failure development, the role of Lp(a) in established heart failure with reduced ejection fraction (HFrEF) versus heart failure with preserved ejection fraction (HFpEF) remains unexplored. Methods: We conducted a retrospective analysis of 387 [...] Read more.
Background/Objectives: While elevated Lp(a) levels are associated with incident heart failure development, the role of Lp(a) in established heart failure with reduced ejection fraction (HFrEF) versus heart failure with preserved ejection fraction (HFpEF) remains unexplored. Methods: We conducted a retrospective analysis of 387 heart failure patients from our institutional database (January 2018–June 2024). Patients were categorized as HFrEF (n = 201) or HFpEF (n = 186) using ICD-10 codes. Categorical variables were compared between heart failure types using the Chi-square test or Fisher’s Exact test, and continuous variables were compared using the two-sample t-test or Wilcoxon rank-sum test, as appropriate. Logistic regression was utilized to assess heart failure type as a function of Lp(a) levels, adjusting for covariates. Spearman correlation assessed relationships between Lp(a) and pro-BNP levels. Results: Despite significant demographic and clinical differences between HFrEF and HFpEF patients, Lp(a) concentrations showed no significant variation between groups. Median Lp(a) levels were 60.9 nmol/dL (IQR: 21.9–136.7) in HFrEF versus 45.0 nmol/dL (IQR: 20.1–109.9) in HFpEF (p = 0.19). After adjusting for demographic and clinical covariates, Lp(a) showed no association with heart failure subtype (OR: 1.001, 95% CI: 0.99–1.004; p = 0.59). Conclusions: Lp(a) levels do not differ significantly between HFrEF and HFpEF phenotypes, suggesting possible shared pathophysiological mechanisms rather than phenotype-specific biomarker properties. These preliminary findings may support unified screening and treatment strategies for elevated Lp(a) across heart failure, pending confirmation in larger studies. Full article
17 pages, 1766 KiB  
Article
The Effects of the Red River Jig on the Wholistic Health of Adults in Saskatchewan
by Nisha K. Mainra, Samantha J. Moore, Jamie LaFleur, Alison R. Oates, Gavin Selinger, Tayha Theresia Rolfes, Hanna Sullivan, Muqtasida Fatima and Heather J. A. Foulds
Int. J. Environ. Res. Public Health 2025, 22(8), 1225; https://doi.org/10.3390/ijerph22081225 - 6 Aug 2025
Abstract
The Red River Jig is a traditional Métis dance practiced among Indigenous and non-Indigenous Peoples. While exercise improves physical health and fitness, the impacts of cultural dances on wholistic health are less clear. This study aimed to investigate the psychosocial (cultural and mental), [...] Read more.
The Red River Jig is a traditional Métis dance practiced among Indigenous and non-Indigenous Peoples. While exercise improves physical health and fitness, the impacts of cultural dances on wholistic health are less clear. This study aimed to investigate the psychosocial (cultural and mental), social, physical function, and physical fitness benefits of a Red River Jig intervention. In partnership with Li Toneur Nimiyitoohk Métis Dance Group, Indigenous and non-Indigenous adults (N = 40, 39 ± 15 years, 32 females) completed an 8-week Red River Jig intervention. Social support, cultural identity, memory, and mental wellbeing questionnaires, seated blood pressure and heart rate, weight, pulse-wave velocity, heart rate variability, baroreceptor sensitivity, jump height, sit-and-reach flexibility, one-leg and tandem balance, and six-minute walk test were assessed pre- and post-intervention. Community, family, and friend support scores, six-minute walk distance (553.0 ± 88.7 m vs. 602.2 ± 138.6 m, p = 0.002), jump, leg power, and systolic blood pressure low-to-high-frequency ratio increased after the intervention. Ethnic identity remained the same while affirmation and belonging declined, leading to declines in overall cultural identity, as learning about Métis culture through the Red River Jig may highlight gaps in cultural knowledge. Seated systolic blood pressure (116.5 ± 7.3 mmHg vs. 112.5 ± 10.7 mmHg, p = 0.01) and lower peripheral pulse-wave velocity (10.0 ± 2.0 m·s−1 vs. 9.4 ± 1.9 m·s−1, p = 0.04) decreased after the intervention. Red River Jig dance training can improve social support, physical function, and physical fitness for Indigenous and non-Indigenous adults. Full article
(This article belongs to the Special Issue Improving Health and Mental Wellness in Indigenous Communities)
Show Figures

Figure 1

6 pages, 9206 KiB  
Interesting Images
“Single Coronary Artery” from Right Sinus—Uncommon Causes of Ischemia with Non-Obstructive Coronary Arteries
by Paweł Muszyński, Marlena Święcicka, Dominika Musiałowska, Dorota Pura, Małgorzata Kazberuk, Anna Kożuchowska-Eljasiewicz, Caroline Sasinowski, Urszula Bajda, Wiktoria Grądzka-Matys and Anna Tomaszuk-Kazberuk
Diagnostics 2025, 15(15), 1971; https://doi.org/10.3390/diagnostics15151971 - 6 Aug 2025
Abstract
Anomalies of coronary artery origins are rare but significant conditions that can range from benign to life-threatening. Early detection through imaging is crucial in preventing adverse outcomes. The treatment strategy varies depending on the type and severity of the anomaly, ranging from pharmacological [...] Read more.
Anomalies of coronary artery origins are rare but significant conditions that can range from benign to life-threatening. Early detection through imaging is crucial in preventing adverse outcomes. The treatment strategy varies depending on the type and severity of the anomaly, ranging from pharmacological treatment to surgery. A 22-year-old male patient, after syncope, after excluding other causes, had an exercise drill test, which was clinically negative and ECG-positive. Angio-CT revealed an undeveloped left main coronary artery (LMCA), and the circulation was supplied through the right coronary artery (RCA). The RCA provides the left anterior descending artery (LAD), and the LAD retrogradely supplies the left circumflex artery (LCX). The myocardial perfusion scintigraphy showed a slight lack of perfusion in the anterior wall (6% of total perfusion). The patient was qualified for further observation. A 77-year-old female underwent cardiac CT due to stenocardia. CT showed a lack of LMCA. The initial segment of the RCA gave rise to the left coronary artery (LCA), which encircled the aortic bulb posteriorly and bifurcated into branches resembling the LCX and LAD. After the Heart Team consultation, the patient was deemed eligible for conservative treatment. Angio-CT is a valuable tool for detecting coronary artery anomalies. Full article
Show Figures

Figure 1

32 pages, 2377 KiB  
Review
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary Intervention
by Claudio Laudani, Daniele Giacoppo, Antonio Greco, Luis Ortega-Paz, Georges El Khoury, Davide Capodanno and Dominick J. Angiolillo
J. Clin. Med. 2025, 14(15), 5536; https://doi.org/10.3390/jcm14155536 - 6 Aug 2025
Abstract
In patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI), antiplatelet therapy is the cornerstone of treatment for secondary prevention. Although dual antiplatelet therapy (DAPT) consisting of aspirin and a P2Y12 inhibitor is the current standard of care, being, respectively, [...] Read more.
In patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI), antiplatelet therapy is the cornerstone of treatment for secondary prevention. Although dual antiplatelet therapy (DAPT) consisting of aspirin and a P2Y12 inhibitor is the current standard of care, being, respectively, recommended for 6 and 12 months in patients with chronic and acute coronary syndrome without a need for oral anticoagulation, the continuous improvement in PCI technology and pharmacology have significantly reduced the need for long-term DAPT. Mounting evidence supports the administration of P2Y12 inhibitor monotherapy, particularly ticagrelor, after a short period of DAPT following PCI as a strategy to reduce bleeding without a trade-off in ischemic events compared to standard DAPT. In addition, there is a growing literature supporting P2Y12 inhibitor monotherapy also for long-term secondary prevention of ischemic events. However, the data to this extent are not as robust as compared to the first-year post-PCI period, with aspirin monotherapy still remaining the mainstay of treatment for most patients. This review aims to summarize the rationale for long-term antiplatelet therapy, the pharmacology of current antiplatelet drugs tested for long-term administration as monotherapy, and current evidence on the available comparisons between different long-term antiplatelet monotherapies in patients with CAD. Full article
Show Figures

Figure 1

17 pages, 251 KiB  
Article
Proximate Composition, Physicochemical Properties and Concentration of Selected Minerals in Edible Giblets of Geese
by Dariusz Kokoszyński, Arkadiusz Nędzarek, Joanna Żochowska-Kujawska, Marek Kotowicz, Marcin Wegner, Karol Włodarczyk, Dorota Cygan-Szczegielniak, Barbara Biesiada-Drzazga and Marcin Witkowski
Foods 2025, 14(15), 2742; https://doi.org/10.3390/foods14152742 - 6 Aug 2025
Abstract
The purpose of this study was to determine the effect of breed and sex (3 × 2) on the basic chemical composition, concentration of some minerals, and physicochemical properties of edible giblets of farm geese. The study material consisted of edible giblets (livers, [...] Read more.
The purpose of this study was to determine the effect of breed and sex (3 × 2) on the basic chemical composition, concentration of some minerals, and physicochemical properties of edible giblets of farm geese. The study material consisted of edible giblets (livers, gizzards, hearts) obtained from 42 geese from three Polish native breeds (Rypin, Suwałki, Kartuzy) at 220 weeks of age. Edible giblets were obtained during goose evisceration from seven males and seven females of each breed. Each bird was an experimental unit. Goose breed and sex had a significant effect on the chemical composition and physicochemical properties of the edible giblets. Rypin geese had higher (p < 0.05) intramuscular fat content in the gizzard and heart, as well as higher protein content in the heart and lower water content in the gizzard, compared to Kartuzy and Suwałki geese. Kartuzy geese, in turn, had higher content of water in the heart, and higher concentrations of phosphorus, calcium, iron, manganese, sodium, and chromium in the liver, compared to Rypin and Suwałki geese. In turn, Suwałki geese had higher concentrations of phosphorus in the gizzard, and potassium, phosphorus, copper, and iron in the heart compared to the hearts of Rypin and Suwałki geese, while Kartuzy and Suwałki geese higher concentrations of sodium, magnesium, zinc, and manganese in hearts than the hearts of Rypin geese. In these studies, the highest lightness (L*) was observed in the liver and heart of Rypin geese, the lowest yellowness (b*) was observed in the gizzard of Suwałki geese, and the highest pH24 and EC24 were observed in the heart of Kartuzy geese. Regardless of breed, males had higher protein, collagen, and intramuscular fat contents in the heart, a higher water content in the gizzard, higher concentrations of potassium, and sodium in the liver and gizzard, copper in the heart and liver, and phosphorus in the gizzard, and less water in the heart and zinc in the liver, as well as higher (p < 0.05) concentrations of iron in the liver and heart compared with females. The breed by sex interaction was significant for intramuscular fat and water content in the gizzard and heart, and protein content in the heart. Significant differences were also noted for EC24 in the liver and heart, yellowness of the gizzard, and concentrations of most labeled minerals in edible giblets. The obtained results indicate that the nutritional value and suitability of edible goose giblets for the poultry industry vary depending on breed and sex. Due to the limited research on the chemical composition and physicochemical properties of goose giblets, further research in this area is necessary in the future. Full article
14 pages, 1750 KiB  
Review
The Role of Imaging Modalities in Estimating Myocardial Viability: A Narrative Review
by Vishakha Modak, Vikyath Satish, Maisha Maliha, Sriram S. Kumar and Panagiota Christia
J. Clin. Med. 2025, 14(15), 5529; https://doi.org/10.3390/jcm14155529 - 6 Aug 2025
Abstract
Myocardial viability assessment plays a critical role in the clinical management of patients with ischemic heart disease, particularly in guiding revascularization decisions. Various non-invasive imaging modalities have been developed and refined to evaluate viable myocardium, each offering unique insights into myocardial perfusion, metabolism, [...] Read more.
Myocardial viability assessment plays a critical role in the clinical management of patients with ischemic heart disease, particularly in guiding revascularization decisions. Various non-invasive imaging modalities have been developed and refined to evaluate viable myocardium, each offering unique insights into myocardial perfusion, metabolism, and contractile function. This review examines the comparative strengths and limitations of key imaging techniques. Understanding the pathophysiological basis and diagnostic capabilities of these modalities enables clinicians to tailor viability assessments to individual patient profiles, ultimately enhancing decision-making and optimizing outcomes in ischemic cardiomyopathy. Full article
Show Figures

Figure 1

22 pages, 8596 KiB  
Article
Cardioprotective and Antihypertensive Effects of Topical Capsaicin in a Rat Model
by Juan Carlos Torres-Narváez, Vicente Castrejón-Téllez, María Sánchez-Aguilar, Agustina Cano-Martínez, Elizabeth Soria-Castro, Julieta Anabell Díaz-Juárez, Israel Pérez-Torres, Verónica Guarner-Lans, Elvira Varela-López, María de la Luz Ibarra-Lara, Gabriela Zarco-Olvera, Alvaro Vargas-González, Pedro L. Flores-Chávez and Leonardo del Valle-Mondragón
Antioxidants 2025, 14(8), 966; https://doi.org/10.3390/antiox14080966 (registering DOI) - 6 Aug 2025
Abstract
TRPV1 regulates neuronal and vascular function mediated by NO and CGRP. Systemic arterial hypertension (SAH) induces an imbalance in vascular mediators NO and CGRP by altering the transport of Ca2+ ions through TRPV1, generating cellular damage. We studied the effect of topical [...] Read more.
TRPV1 regulates neuronal and vascular function mediated by NO and CGRP. Systemic arterial hypertension (SAH) induces an imbalance in vascular mediators NO and CGRP by altering the transport of Ca2+ ions through TRPV1, generating cellular damage. We studied the effect of topical capsaicin (CS) treatment on cardiac mechanical work, oxidative stress (CAT, NO, BH4, and BH2), cellular damage (MDA, MTO, and 8HO2dG), and inflammation (IL-6 and TNFα), generated by SAH, which was induced by L-NAME, in male Wistar rats. CS was added to a moisturizing cream and applied to the abdomen of animals for two weeks. Experimental groups were as follows: (1) Control, (2) Control + Cream, (3) Hypertensive, and (4) Hypertensive + Cream. Hearts were exposed to ischemia-reperfusion (I-R) using the Langendorff technique to study the potential cardioprotection of CS. Expression of SOD1, SOD2, catalase, eNOS, pNOS, TRPV1, and CGRP in cardiac tissue was evaluated. In the Hypertensive group, TRPV1 activation by CS (Hypertensive + Cream) reduced oxidative stress (OS), decreasing cellular damage and inflammation and increasing CAT, modulating biochemical and tissue alterations induced by OS generated by SAH. In parallel, an increase in tissue levels and the expression of CGRP, TRPV1, and eNOS, induced by CS, was observed. These findings indicate that pretreatment with CS attenuates cardiac I-R and SAH injury in rats. The cardioprotective mechanism may be based on TRPV1-mediated CGRP overexpression. Full article
(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
Show Figures

Graphical abstract

18 pages, 3562 KiB  
Article
Robust U-Nets for Fetal R-Peak Identification in Electrocardiography
by Peishan Zhou, Stephen So and Belinda Schwerin
Algorithms 2025, 18(8), 487; https://doi.org/10.3390/a18080487 - 6 Aug 2025
Abstract
Accurate fetal R-peak detection from low-SNR fetal electrocardiogram (FECG) signals remains a critical challenge as current NI-FECG methods struggle to extract high SNR FECG signals and conventional algorithms fail when signal quality deteriorates. We proposed a U-Net-based method that enables robust R-peak detection [...] Read more.
Accurate fetal R-peak detection from low-SNR fetal electrocardiogram (FECG) signals remains a critical challenge as current NI-FECG methods struggle to extract high SNR FECG signals and conventional algorithms fail when signal quality deteriorates. We proposed a U-Net-based method that enables robust R-peak detection directly from low-SNR FECG signals (0–12 dB), bypassing the need for high-SNR inputs that are clinically difficult to acquire. The method was evaluated on both real (A&D FECG) and synthetic (FECGSYN) databases, comparing against ten state-of-the-art detectors. The proposed method significantly reduces false predictions compared to commonly used detection algorithms, achieving a PPV of 99.81%, an SEN of 100.00%, and an F1-score of 99.91% on the A&D FECG database and a PPV of 99.96%, an SEN of 99.93%, and an F1-score of 99.94% on the FECGSYN database. Further investigation of robustness in low-SNR conditions (0 dB, 5 dB, and 10 dB) achieved 87.38% F1-score at 0 dB SNR on real signals, surpassing the best-performing algorithm implemented in Neurokit by 13.58%. In addition, the algorithm showed ≤2.65% performance variation across tolerance windows (50 reduced to 20 ms), further underscoring its detection accuracy. Overall, this work reduces the reliance on high-SNR FECG signals by reliably extracting R-peaks from suboptimal signals, providing implications for the reliability of fetal heart rate variability analysis in real-world noisy environments. Full article
(This article belongs to the Special Issue Advancements in Signal Processing and Machine Learning for Healthcare)
Show Figures

Figure 1

15 pages, 17231 KiB  
Article
ArfGAP with Dual Pleckstrin Homology Domains 2 Promotes Hypertrophy of Cultured Neonatal Cardiomyocytes
by Jonathan Berthiaume, Audrey-Ann Dumont, Lauralyne Dumont, Marie-Frédérique Roy, Hugo Giguère and Mannix Auger-Messier
Int. J. Mol. Sci. 2025, 26(15), 7588; https://doi.org/10.3390/ijms26157588 - 6 Aug 2025
Abstract
Cardiomyocyte hypertrophy is regulated by several factors, including the ADP-ribosylation factor (Arf) family of small G proteins, among others. For instance, ArfGAP with dual pleckstrin homology domains 1 (Adap1) exerts an anti-hypertrophic effect in cultured cardiomyocytes. Its homologous protein, Adap2, is also expressed [...] Read more.
Cardiomyocyte hypertrophy is regulated by several factors, including the ADP-ribosylation factor (Arf) family of small G proteins, among others. For instance, ArfGAP with dual pleckstrin homology domains 1 (Adap1) exerts an anti-hypertrophic effect in cultured cardiomyocytes. Its homologous protein, Adap2, is also expressed in the heart but its role remains elusive. To elucidate its function, we investigated the effects of adenoviral-mediated overexpression of Adap2 in cultured neonatal rat ventricular myocytes under both basal and pro-hypertrophic conditions, employing a range of microscopy and biochemical techniques. Despite minimal detection in neonatal rat hearts, Adap2 was found to be well expressed in adult rat hearts, being predominantly localized at the membrane fraction. In contrast to Adap1, overexpression of Adap2 provokes the robust accumulation of β1-integrin at the cellular surface of cultured cardiomyocytes. Interestingly, overexpressed Adap2 relocalizes at the sarcolemma and increases the size of cardiomyocytes upon phenylephrine stimulation, despite attenuating Erk1/2 phosphorylation and Nppa gene expression. Under these same conditions, cardiomyocytes overexpressing Adap2 also express higher level of detyrosinated tubulin, a marker of hypertrophic response. These findings provide new insights into the pro-hypertrophic function of Adap2 in cardiomyocytes. Full article
Show Figures

Figure 1

17 pages, 926 KiB  
Review
Advancing Heart Failure Care Through Disease Management Programs: A Comprehensive Framework to Improve Outcomes
by Maha Inam, Robert M. Sangrigoli, Linda Ruppert, Pooja Saiganesh and Eman A. Hamad
J. Cardiovasc. Dev. Dis. 2025, 12(8), 302; https://doi.org/10.3390/jcdd12080302 - 5 Aug 2025
Abstract
Heart failure (HF) is a major global health challenge, characterized by high morbidity, mortality, and frequent hospital readmissions. Despite the advent of guideline-directed medical therapies (GDMTs), the burden of HF continues to grow, necessitating a shift toward comprehensive, multidisciplinary care models. Heart Failure [...] Read more.
Heart failure (HF) is a major global health challenge, characterized by high morbidity, mortality, and frequent hospital readmissions. Despite the advent of guideline-directed medical therapies (GDMTs), the burden of HF continues to grow, necessitating a shift toward comprehensive, multidisciplinary care models. Heart Failure Disease Management Programs (HF-DMPs) have emerged as structured frameworks that integrate evidence-based medical therapy, patient education, telemonitoring, and support for social determinants of health to optimize outcomes and reduce healthcare costs. This review outlines the key components of HF-DMPs, including patient identification and risk stratification, pharmacologic optimization, team-based care, transitional follow-up, remote monitoring, performance metrics, and social support systems. Incorporating tools such as artificial intelligence, pharmacist-led titration, and community health worker support, HF-DMPs represent a scalable approach to improving care delivery. The success of these programs depends on tailored interventions, interdisciplinary collaboration, and health equity-driven strategies. Full article
Show Figures

Graphical abstract

Back to TopTop